Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...
Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...
As you round out your first trimester, you may start to wonder: What color hair will your little one have? Will they look more like you or your partner? Will they be a fearless daredevil like your ...
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society ...
Usually, you have a very small amount of alpha-fetoprotein (AFP) in your body. But when you have liver disease, some types of cancer, or are pregnant, you'll usually have more of it in your blood. An ...
(San Diego, CA) August 21, 2009 – GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this ...
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker blood test designed to help detect ...
Testing genetic markers for Hardy–Weinberg equilibrium (HWE) is an important tool for detecting genotyping errors in large-scale genotyping studies. For markers at the X chromosome, typically the χ 2 ...
CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The cardiac marker testing industry is poised for significant advancements in the near future, driven by breakthroughs in diagnostic technologies and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback